journal article·2024-08-13Open access

Surfactant-Mediated Assembly of Precision-Size Liposomes

Ivan S. Pires, Jack R. Suggs, Isabella S. Carlo, DongSoo Yun, Paula T. Hammond, Darrell J. Irvine

Chemistry of Materials· Volume 36· Issue 15

Abstract

Liposomes can greatly improve the pharmacokinetics of therapeutic agents due to their ability to encapsulate drugs and accumulate in target tissues. Considerable effort has been focused on methods to synthesize these nanocarriers in the past decades. However, most methods fail to controllably generate lipid vesicles at specific sizes and with low polydispersity, especially via scalable approaches suitable for clinical product manufacturing. Here, we report a surfactant-assisted liposome assembly method enabling the precise production of monodisperse liposomes with diameters ranging from 50 nm to 1 μm. To overcome scalability limitations, we used tangential flow filtration, a scalable size-based separation technique, to readily concentrate and purify the liposomal samples from more than 99.9% of detergent. Further, we propose two modes of liposome self-assembly following detergent dilution to explain the wide range of liposome size control, one in which phase separation into lipid-rich and detergent-rich phases drives the formation of large bilayer liposomes and a second where the rate of detergent monomer partitioning into solution controls bilayer leaflet imbalances that promote fusion into larger vesicles. We demonstrate the utility of controlled size assembly of liposomes by evaluating nanoparticle uptake in macrophages, where we observe a clear linear relationship between vesicle size and total nanoparticle uptake.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 500 Main Street, Cambridge, Massachusetts 02139, United States

Department of Chemical Engineering, Massachusetts Institute of Technology, 21 Ames Street, Cambridge, Massachusetts 02139, United States

Department of Biological Engineering, Massachusetts Institute of Technology, 25 Ames Street, Cambridge, Massachusetts 02139, United States

Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States

Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02139, United States

Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, United States

Funding

Howard Hughes Medical Institute · National Cancer Institute · Marble Center for Nanomedicine · Ragon Institute of Mass General, MIT, and Harvard

References (45)

Show source-provided references
1. 10.1016/j.jconrel.2012.03.02010.1016/j.jconrel.2012.03.020 ↗
2. 10.1038/s41578-021-00358-010.1038/s41578-021-00358-0 ↗
3. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
4. 10.1002/anbr.20210010910.1002/anbr.202100109 ↗
5. 10.3390/molecules2704137210.3390/molecules27041372 ↗
6. 10.1186/1556-276X-8-10210.1186/1556-276X-8-102 ↗
7. 10.1016/0006-291X(81)91930-610.1016/0006-291X(81)91930-6 ↗
8. 10.3390/membranes804010310.3390/membranes8040103 ↗
9. 10.1007/s11095-004-1873-z10.1007/s11095-004-1873-z ↗
10. 10.1016/j.memsci.2020.11871210.1016/j.memsci.2020.118712 ↗
11. 10.1016/j.cej.2023.14266410.1016/j.cej.2023.142664 ↗
12. 10.1016/0003-2697(80)90269-910.1016/0003-2697(80)90269-9 ↗
13. 10.1002/0471142735.im1810s5210.1002/0471142735.im1810s52 ↗
14. 10.1021/cr078381n10.1021/cr078381n ↗
15. 10.1016/S0304-4157(00)00006-X10.1016/S0304-4157(00)00006-X ↗
16. 10.1080/08982104.2020.173040110.1080/08982104.2020.1730401 ↗
17. 10.1016/0005-2736(78)90225-010.1016/0005-2736(78)90225-0 ↗
18. 10.1002/btm2.1045310.1002/btm2.10453 ↗
19. 10.1021/acsnano.0c0310910.1021/acsnano.0c03109 ↗
20. 10.1002/adfm.20150438510.1002/adfm.201504385 ↗
21. 10.1016/j.jconrel.2017.07.03110.1016/j.jconrel.2017.07.031 ↗
22. Eliaz R. E. · Cancer Res. · 2001 · 61 · 2592
23. 10.1016/0005-2736(90)90437-S10.1016/0005-2736(90)90437-S ↗
24. 10.1016/j.bpj.2013.06.00710.1016/j.bpj.2013.06.007 ↗
25. 10.1021/j100252a03110.1021/j100252a031 ↗
26. 10.1371/journal.pcbi.100310610.1371/journal.pcbi.1003106 ↗
27. 10.1039/f2978740160710.1039/f29787401607 ↗
28. 10.1016/S0927-7757(00)00516-110.1016/S0927-7757(00)00516-1 ↗
29. 10.1038/s41467-021-26924-210.1038/s41467-021-26924-2 ↗
30. 10.1146/annurev.biochem.72.121801.16150410.1146/annurev.biochem.72.121801.161504 ↗
31. 10.1021/bi00128a01610.1021/bi00128a016 ↗
32. 10.1021/bi00456a00510.1021/bi00456a005 ↗
33. 10.1016/j.ultramic.2019.11284910.1016/j.ultramic.2019.112849 ↗
34. 10.1016/j.bbamem.2007.06.02410.1016/j.bbamem.2007.06.024 ↗
35. 10.1016/S0300-9084(00)00209-110.1016/S0300-9084(00)00209-1 ↗
36. 10.1016/0005-2736(91)90268-D10.1016/0005-2736(91)90268-D ↗
37. 10.1155/2011/72724110.1155/2011/727241 ↗
38. 10.1016/j.jconrel.2010.03.01110.1016/j.jconrel.2010.03.011 ↗
39. 10.1211/jpp.59.1.001010.1211/jpp.59.1.0010 ↗
40. 10.1080/1061186060083437510.1080/10611860600834375 ↗
41. 10.3390/nano1108196310.3390/nano11081963 ↗
42. 10.1146/annurev.immunol.17.1.59310.1146/annurev.immunol.17.1.593 ↗
43. 10.1021/bi00545a00110.1021/bi00545a001 ↗
44. 10.1007/BF0196007010.1007/BF01960070 ↗
45. 10.1016/0009-3084(93)90035-210.1016/0009-3084(93)90035-2 ↗